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Hollow fiber occlusion due to maldistribution of blood? T. Agishi,
K. Ow and Y. Nose. Tokyo Women's Medical College, Tokyo,
Japan and Department of A rt(/Icial Organs, Cleveland Clinic,
Cleveland, Ohio, U.S.A. One of the disadvantages of the Hollow
Fiber Artificial Kidney (HFAK) is the clotting tendency inside
capillaries which may result in performance deterioration. Com-
parisons were made between C,,re, Cer and examined im-
mediately after the start of clincial hemodialysis (HD) and im-
mediately before completion of HD. One out of four or five Cordis
Dow Model 4 HFAKs decreased in performance to 25 to 30% after
five to six hours of HD, and the rest of them showed only slight
deterioration. In the former, "central clotting" was dominantly
observed. As in the clincial investigation, blood distribution in the
capillary bundle was examined in vitro in a cap-off HFAK in which
a cap of the blood compartment was removed and three metal out
lets were stuck to different portions of the capillary bundle, central
intermediate and peripheral, for collection of samples. Results
showed that the central blood flow rate was one-fourth to one-fifth
less than peripheral in specific Q, and intermediate, less than
peripheral. A divided clearance study showed consistent results. It
is concluded that the "central clotting" frequently observed is due
to improper distribution of blood.
A comparison of short and long hemodialysis. F. Alvarez- Ude, M.
Ward, R. W. Elliott, P. R. U/dali, R. Wilkinson, D. N. S. Kerr, G.
D'Amico, E. Petrel/a, M. Gentile, M. Romagnoni, G. Orlandini, L.
Luciani and C. Ferrandes. Newcastle-upon-Tyne, England. Short
hemodialysis prolongs life with low annual mortality and economy
in staff but does it exact a penalty in increased morbidity? To
answer this question we have compared 69 patients on long dialysis
(L) in a British center with 71 patients on short dialysis (S) in an
Italian center. The groups were similar in primary diagnosis,
residual renal function and mean age (L,39; S,40 yr) but the long
dialysis patients had a higher proportion of females (L,4l%; S,22%)
and longer experience of dialysis (mean duration/patient: L,26;
S,19 months). Patients on short dialysis had a higher mean pre-D
plasma urea (L,138; S,178 mg/tOO ml) and creatinine (L,12.0;
S, 13.8 mg/l00 ml) levels but control of potassium (L,5.0; S,4.8m-
Eq/liter), calcium (L,9.9; S,9.4 mg/l00 ml) and phosphate (L,5.4;
S,5.0 mg/tOOml) levels was not inferior. Blood pressure control
was better in the long dialysis group (96% of L and 73% of S were
normotensive) but mean hemaglobin was higher in S (8.9 g/lOO ml)
than L (7.6 g/l0O ml) patients. These differences can be partly ex-
plained by a higher proportion being anephric in the L group
(L,22%; S,8%). Morbidity in the two groups has been compared by
using a common questionnaire and physical examination stan-
dardized by exchange of observers. No major differences have
emerged to date; full details will be presented with correction for
dialysis duration, age, sex and residual function.
A full account of the meeting will appear in the Proceedings of the
EDTA by January 1976.
AB Ga,nbro (Sweden) has kindly assisted with the publication of
the abstracts.
Only those abstracts that have been selected for presentation are
included.
® 1975, by the International Society of Nephrology.
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Cyclophosphamide (CP) as a substitute for azathioprine (AZ)
after renal transplantation (RT). J. Andreu, A. Caralps, A. Brulles,
I. Lloyeras, J. Masrambn, J. MaGil- Vernet. U. T.R. Faculty of
Medicine, University of Barcelona, Spain. Eighteen patients
received CP as a substitute for AZ. The time of onset of this treat-
ment ranged between 1.5 and 47 months after RT. The substitution
was done because of evidence of hepatitis. Nine patients had
received a renal graft from a living related donor and nine from
cadavers. We compare the graft evolution before and after the
treatment with CP. Twelve patients showed no modification on the
graft evolution. In four patients the renal function decreased but it
was not attributed to the change of the drug. Two patients showed
intolerance attributable to the change of the drug. None of the
seven patients receiving 50 to 100 mg/day of CP and none of the
three patients receiving 50 mg/day showed impairment on the
evolution attributable to the change of the drug. Four of eight
Patients receiving CP doses of 50 to 100 mg/week showed an im-
pairment of the evolution attributable to the change of the drug. In
three of these four cases, the CP dose was increased up to 50 mg/-
day, the renal function being stabilized in two cases. We conclude
that CP is a good substitute of the AZ in renal transplanted
patients with hepatitis. The adequate dose seems to range between
0.7 and I mg/kg/day.
Efferent arteriole (EA) in glomerular hemodynamics. V. E.
Andreucci, A. Dal Canton, A. Corradi and L. Migone. Division of
Nephrology. University of Naples, Second Faculty of Medicine,
Naples, Italy; and II C/mica Medica, University of Parma, Parma,
Italy. Anatomical studies have shown that efferent arterioles of
superficial nephrons have a thin wall with few muscle cells. This
study was undertaken to evaluate the role of superficial efferent
arterioles in glomerular hemodynamics. Hemodynamic pressure in
glomerular capillaries (F0) and at the "welling point" of efferent
arterioles (EAP) in superficial nephrons of mutant Wistar rats with
surface glomeruli was directly measured, by micropuncture, with a
servo-nulling device in control conditions, during norepinephrine,
epinephrine and dopamine infusion in normal and hemorrhagic
rats, and in hypertensive rats. EAP/PG ratio remained constant in
all conditions under study indicating that about 60% of PG is con-
stantly dissipated by the efferent arteriole. The results indicate that
the site of action of catecholamines and neurohumoral factors
operating in hemorrhagic hypotension and acute hypertension is
limited to afferent arterioles, at least in superficial nephrons, and,
that superficial nephron changes in EAP are due to PG changes.
Hypertension in transplanted patients. C. Bachy and C. van
Ypersele. Renal Unit, Clmniques Universitaires St. Pierre, Louvain,
Belgium. This study evaluates the incidence, pathogenesis and
long-term history of hypertension (HT) in transplanted patients.
Eighty-five patients in whom a detailed follow-up was available for
a period ranging from 18 to 78 months were reviewed. Incidence of
HT (diastolic blood pressure [DSP] >90 mm Hg) increased over
the first 4 months after transplantation (30, 32, 53 and 69% after I,
2, 3 and 4 months) and remained stable thereafter (66, 63, 69, 56,
59 and 56% after 6, 12, 24, 36, 48 and 60 months). In half of these
patients DBP was >100 mm Hg. Contrary to previous short-term
studies, no significant relationship was found between DBP and
steroid dosage. There was no difference between mean steroid
dosage of hypertensive (HT) and normotensive (NT) subjects. The
incidence of elevated serum creatinine (SCr) was higher in HT than
124 Abstracts
in NT. However, a positive correlation between SCr and DBP was
found in only one patient out of 21, whose DBP had varied by
more than 10 mm Hg during a 36-month follow-up. This suggests
that renal impairment is not the major cause of HT. Renal artery
stenosis was found in 2% of the patients. Survival at 18, 36 and 60
months was not modified by HT. Long-term cardiovascular conse-
quences of HT were significantly more severe in 10 patients whose
HT was stable during 36 months, than in a comparable group of Ii
NT patients. We conclude that HT is a frequent complication after
renal transplantation; several etiological factors were implicated in
Its genesis. HT increases cardiovascular lesions but not mortality
within the time limits of this study.
Plasma renin activity (PRA) and plasma aldosterone (PA) in
hypertensive kidney allograft recipients. K. Baumann, J. Hussberger,
U. Schmied, W. Vetter, F. Largiader and U. Bins wanger (Inir. by F.
Brunner). Department of Internal Medicine and Surgery, University
of Zurich, Switzerland. PRA and PA as possible mechanisms caus-
ing hypertension were measured under basal and stimulatory con-
ditions in eight hypertensive and nine normotensive patients.
Kidney function was stable (serum creatinine <2 mg/IOU ml).
Maintenance treatment was 10 mg of prednisone and 100 to 200
mg of azathioprine; antihypertensive drugs were withdrawn one
week prior to the study. Results in hypertensive vs. normotensive
patients (mean + I SCM)): PRA (ng/ml X 3 hr) basal 2.45 +
1.16 vs. 2.08 + 0.37; stimulated, 4.22 1.53 vs. 2.54 0.49; PA
(pg/mi) basal, 50 + 22 vs. 41 + 13; stimulated, 1.71 73 vs. 131
72. Mean values were not significantly different, although
hypertensive patients tended to have higher basal and stimulated
PRA. Three patients in this group had high basal PRA (>3 ng/ml
)< 3 hr), one also high stimulated PRA (>10 ng/ml X 3 hr). One of
the nine normotensive patients had a high basal PRA. No correla-
tion with renal artery murmers was found. Conclusion: PRA can
be elevated in some hypertensive kidney recipients. Hypertension
with normal PRA and normotension with high PRA indicate other
mechanisms to be involved in the pathogenesis of high blood pres-
sure in these patients.
Blood pressure-sodium/volume-renin interrelations in mild renal
failure. C. Bereua-Piccoli, P. Weidmann, F. Reubi, F. Sieffen and A.
Blumberg. Medical University Policlinic, Berne, Switzerland. The
pathogenesis of hypertension associated with mild renal failure is
largely unknown. Interrelations between blood pressure (HP), ex-
changeable sodium (Nae), blood volume (BV) and plasma renin ac-
tivity (PRA) were studied in 31 normal subjects and 25 patients
(pts) with mild renal failure (mean serum creatinine, 2.2 1.0
(±sD) mg/IOU ml). Normal subjects (mean BP, 91 7 mmHg)
and 20 pts with high BP(138 21 mmHg) showed significant dif-
ferences (P < 0.01) in Nae (51.1 3.9 vs. 55.9 8.0 mEq/kg of
lean body mass), PRA (2.2 1.2 vs. 4.2 + 5.2 ng/mI/hr), and in
the products IjiPRA X NUe (176 30 vs. 211 53) or InPRA x BV
(278 vs. 318 81). Five pts with normal BP(mean BP, 106
7 mmHg) did not differ from normal subjects. Individually, BV or
I5RA did not correlate with BP. However, HP correlated (P <
0.001) with Na (r 0.43) and even closer with InPRA x BV (r
0.49) or InPRA x Nae (r = 0.52). This suggests: abnormalities in
the physiological sodium/volume-renin feedback mechanism may
occur very early in renal failure. Hypertension associated with mild
renal failure may be partly due to a deranged relationship between
the body sodium/volume state and circulating renin.
Blood parathyroid hormone concentrations and sensitivity of para-
thyroid glands to hypercalcemia after successful renal transplanta-
tion. J. Bernheim, H. Touraine, M. Labeeuw and]. Traeger. Clinique
de nêphrologie, Lyon, France. We have measured every week, for
5 to 12 weeks, after renal transplantation (RT), the blood levels of
immunoreactive parathyroid hormone (PTH) in eight patients. De-
crease of PTH level appeared rapidly between 2 and 20 days after
the RT. The PTH level was >250 #Eq/ml at the beginning of the
study in each case. After that, a decrease was observed either
rapidly or more slowly, but return to normal range (±50 stEq/ml)
did not appear within the first two months. A three-hour calcium
infusion test (CT) was performed in eight patients: in one, 15 days
after RT; in six, one month after; and in the last, four years after
RT. PTH was analyzed in the peripheral blood at time 0-3-6-24 hr.
Parathyroid glands (PGappeared insensitive to the CT only in the
case tested after two weeks. In all the others, a normal decrease of
PTH level was found at 3 hr, but an unusual secondary rebound
was observed at 24 hr. The basic PTH level was either normal or
elevated. From our results, we conclude that the PTH levels
decrease more or less rapidly, but remain above normal values for
several weeks after restitution of good renal function. The PG seem
to be insensitive in the first days following RT but are sensitive to
CT after one month. Finally, the PG hypersensitivity was
demonstrated, in each case, by the presence of secondary rebound
after the CT.
Plasma norepinephrine concentrations in regular hemodialysis
patients. H. M. Brecht, W. Ernst and K. M. Koch. Department of
Nephrology, Centre of laternal Medicine, University of Frankfurt,
West Germany. Recent studies have indicated an insufficiency of
the autonomic nervous system in uremia. However, data on plasma
eatccholamines and their response to orthostatic stimulation in
regular hemodialysis patients (RH) are lacking. Blood samples for
the fluorometric determination of norepinephrine (NE) were taken
from 15 normal subjects (C) and from 28 RH consisting of 13 nor-
motensives (RH-N), 9 hypertensives (RH-I-I, and 6 binephrecto-
mized normotensives (RH-BN) after a) four hours in a supine
position h) seven minutes of standing and c) two hours of walking.
Under all test conditions, the mean values of NE(±SEM) ex-
pressed in ng/liter in all RH were significantly higher than the cor-
responding values found in C.
C RH-N RH-H R1-l-BN
a) supine 135 + IS 413 + 21 367 28 508 + 69
b) standing 373 + 24 616 + 46 557 35 665 + 53
c) walking 233 22 640 43 522 27 698 66
Both RH and C showed a significant increase in NE in response to
seven minutes of standing. In contrast to C, NE in RH did not
drop significantly after two hours of walking. The results suggest
that in RH the sympathetic nervous system plays a minor role in
hypertensive blood pressure regulation. The elevated levels of cir-
culating NE found in RH might partly be due to a disturbance in
metabolism and to a diminished or abolished renal clearance of
NE. The fact that the increased NE in plasma is not accompanied
by elevated blood pressure in RH-N and RH-BN points to an im-
paired reactivity of the vascular system in RH.
Indolic tryptophan metabolism in uremia. D. J. Byrd, H. W.
Berthold, F. K. Trefz, W. Kochen, H. W. SchOler and K. Schdrer.
Department of Pediatrics and Urology, University of Heidelberg,
Federal Republic of Germany. Little is known about tryptophan
(Try) metabolism in uremia. Thin-layer and high-pressure liquid
chromatographic studies of urine, serum and dialysis fluid of
patients (N = 9; age, 12 to 32 yr) with advanced renal failure in the
basal state and after oral Try load (25 mg/kg) demonstrate that
derangements do occur: urinary indole-3-carboxylic acid (l-3CA)
and serum and urinary indole acetic acid were above normal. In-
dole lactic acid was increased in serum but not in urine, in urine
were pathological amounts of indole-3-carbaldehyde. Urinary Try
was below normal. The same metabolites were found in dialysis
fluid as in urine, but the concentration of IAA and I-3CA fell only
slightly over seven hours while that of other metabolites decreased
below detectable limits. The chief effect of Try load was the excre-
tion of N-acetyl-Try. Basal serum N-acetyl-Try in one patient was
above 2 mg/lOU ml while total serum Try was normal at 1.57
mg/lOU ml. The study indicates that the acetylation of Try has
become a major pathway of Try metabolism in uremic patients.
Angiotensin II degradation and blood pressure in chronic renal
failure. A. Carpi, R. Palla, R. Puntoni and L. Donato. C. N. R.
Laboratory of Clinical Physiology, 2nd Medical Clinic, University of
Pisa, Pisa, Italy. Angiotensin II metabolic clearance rate (All-
MCR), angiotensin II arterio-venous extraction (All-F), arterial
blood pressure, cardiac output (CO) and total peripheral resistance
(TRP) were measured in 9 normal and 15 hypertensive patients
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with chronic renal failure (CFR), 13 of which were on regular
hemodialytic treatment and 2 affected by chronic pyeionephritis.
Patients with CRF tended to have normal to moderately increased
A1l-MCR, ranging from 800 to 1646 ml/min/m2BSA, as com-
pared to 1044 104 ml/min/m2BSA in normals, and AII-E values
higher (from 47 to 93%) in comparison to normals (41.1 7.8). A
strong positive correlation was found between AII-MCR and
mean blood pressure level (MBP) in CFR cases (P = 0.001),
whereas no correlation was discernible in normals, possibly due to
the narrow scatter of both MBP and AI1-MCR. On the other hand
a strong correlation between All-F and TPR was found when the
two groups were analyzed both jointly or separately (P = 0.001 in
all instances). These data suggest that All degradation is closely
linked to the control of peripheral vascular resistance both in nor-
mals and CRF. In normals, however, autoregulation of cardiac
output maintains MBP and Al1-MCR within a relatively narrow
range in the presence of different values of TPR and of the related
All extraction (MBP = TPR >< CO; AI1-MCR =A1l-E X CO).
Lack or impairment of this autoregulatory mechanism in CRF ex-
plains the observed proportional increase of MBP and AII-MCR.
Clinical experience of kidney preservation by continuous hypother-
mic albumin perfusion without membrane oxygenation. G. Claes and
I. Blohtnk. Department of Surgery I, Sahigren's Hospital, Gothen-
burg, Sweden. Membrane oxygenation and plasma perfusion have
previously been regarded essential for continuous hypothermic
perfusion of kidneys. We have previously reported on the exchange
of plasma to albumin as perfusate, a simplification which also
resulted in better results of organ preservation. We have also
recently reported on another major simplification of the system,
omitting the membrane oxygenator. In experimental studies sur-
face oxygenation was sufficient for 96 hr preservation with ade-
quate renal function after transplantation. The new surface ox-
ygenation system was introduced into the clinical preservation
program in 1974. Thirty kidneys were stored in the new Gambro
preservation unit during 17 to 48 hr. Immediate onset of function
after transplantation was obtained in 70%. Kidneys with ATN
were all damaged by warm ischemia prior to preservation. There
was no correlation between preservation time and Onset of func-
tion. Also, kidneys stored for 48 hr had an immediate onset of
function. Compared to the previous material of kidneys stored by
continuous perfusion with membrane oxygenation, the results with
this system were unchanged. The simplified system for continuous
hypothermic perfusion in the new Gambro unit with surface Ox-
ygenation turned out to be equally efficient for organ preservation
as the old method with membrane oxygenation. The direct surface
oxygenation in the new system is less complicated and less expen-
sive, therefore offering a major advantage in continuous perfusion.
Comparison of the influence of parathyroid hormone and
calcitonin on plasma levels of adenosine 3'S'monophosphate and
electrolytes in normal and anephric subjects. S. Czekalski and K.
Baczyk. Department of Nephrology, Medical A cadetny, Poznah,
Poland. The purpose of this study was to estimate whether the
other target tissues than the kidney are responsive to parathyroid
hormone (PTH) and calcitonin (CT) in anephric man. PTH in-
Iused over one hour in six normal subjects produced a sharp
three- to four-fold increase in plasma level of adenosine 35'-
monophosphate (cAMP) whereas CT caused only minimal in-
crease. In anephric subjects on regular dialysis treatment, plasma
cAMP was three to four-fold higher than in normals before the in-
fusion of PTH or CT. PTH administration did not immediately
modify the plasma level of nucleotide but it rose significantly 30
mm after the infusion. This delayed response in these patients was
much less marked than in normals. CT infusion had no effect on
plasma cAMP. Plasma phosphate, calcium, magnesium, bicar-
bonate and sodium did not change during and one hour after the
infusion of these hormones, both in normal and anephric subjects.
It was concluded that the kidneys seem to be the main source of
cAMP in plasma after PTH and CT administration. Nevertheless,
in anephric subjects other sources of production of cAMP may
play a role after PTH administration.
Thyroid function in chronic renal failure. P. Dandona, D. Newton,
A. Champion and M. M. Platts. Royal Hospital, Sheffield, United
Kingdom. Recent reports suggest that the frequency of low serum
PB! concentrations in patients with chronic renal failure may be
higher than that expected in the normal population. We have hence
investigated in detail the thyroid function in 13 patients on
hemodialysis with chronic renal failure. Serum thyroxine (T4) and
thyrotropin (TSI-1) concentrations were measured and iv. thyrotropin
releasing hormone (TRH) tests were carried out on all patients. In
patients who had been on hemodialysis for less than a year, serum
T and TSH concentrations were normal, whereas those who had
been dialyzed for longer periods had lower serum T4 and higher
serum TSH concentrations. The magnitude of TRH-induced TSH
release was significantly diminished in all patients, the release being
totally abolished in patients with raised basal TSH concentrations.
It is suggested that patients with chronic renal failure have an in-
creased tendency to develop biochemical hypothyroidism while on
hemodialysis, that they are relatively insensitive to i.v. TRH and
that the integrity of the thyroid pituitary axis is maintained.
Serum levels and glomerular deposits of some complement compo-
nents in 175 cases of glomerulonephritis (GN). A. Durante, C.
Rovati, G. Barbiano di Belgiojoso, and L. Minetti. Divisione di
Nefrologia, Ospedale Maggiore Ca Granda, Milano, Italy. The
simultaneous examination of serum levels and glomerular deposits
of C Iq, C4, C3 and C3A was performed in 175 cases of GN. In
normocomplementemic cases, at immunofluorescence were found:
in minimal changes (10 cases), scanty deposits of C3; in focal
glomerulosclerosis (22), deposits of C3, CIq, and C4; in mem-
branous GN (18), in crescentic Gn (7) and in Goodpasture's
syndrome GN (2), constant deposits of C3 with lesser C Iq and C4;
in mesangial IgA-lgG deposits GN (30) and in rheumatoid purpura
GN (7), C3 alone. In acute GN (13) during the first two weeks (5)
low serum levels of C3, C4 and Clq (only in one case of C3A)
and bright deposits of C3 (in three cases with C3A) were observed;
between the second and sixth week (3) low serum levels and de-
posits of C3 were found; later (22) normal serum levels and very
scanty deposits of C3 were found. In membranoproliferative GN
(19), serum C3 in 16 cases (also C4 in 2) was reduced; by immuno-
fluorescence, 15 cases showed deposits of C3, C4 and Cl q, and the
remaining 4 cases (with low serium C3), C3 alone. In lupus GN
(20), 10 cases showed normal levels of C3 (2 also low levels of
Clq and C4) and deposits of C3, Clq (4) and C4 (5); 5 eases
showed low serum C3 (2 also low serum C4 and Clq) and im-
portant deposits of C3, C lq and C4 (C3A in 1 case only); the re-
maining S cases had very low serum C3, and low Clq and C4 (and
C3A in 3), and deposits ofC3, Clq and C4(C3A in 2). In IgG-IgM
essential cryoglobulmnemia GN (10), serum C3 was reduced in
6, and deposits of C3 were found in 10, of C4 in 5, of Clq in 5
and of C3A in 2. An inverse correlation between serum levels and
glomerular deposits of complement components was seen in only a
few cases of acute GN and lupus GN.
Predisposing factors to priapism in hemodialysis patients. W. Fass-
binder, U. Frei, R. Issantier, K. M. Koch, C. Mion, S. Shaldon
and A. Slingeneyer. Departments of Nephrology, University of
Frankfurt, Germany, and University of Mon tpellier, France.
Androgen therapy (AT) has been incriminated as a predisposing
factor favoring the development of dialysis priapism (DP).
However, the absence of DP in 59 male home hemodialysis
patients (MHI-IP) receiving continuous parenteral AT at one cen-
ter (group 1) compared with a 20% incidence of DP in 44 MHHP
receiving AT at another center (group 2) prompted a comparative
evaluation of alternative potential predisposing factors. Factors
compared were: dialysis techniques; heparin dosage; platelet func-
tion and coagulation tests; blood levels of fibrinogen. triglycerides,
cholesterol; hematocrit (hct); sexual performance; supplementary
therapy; dialysate composition. Only the following differences
were found: I) hct was higher in group 2 (30.9% 5.0 so) when
compared with group I (28.2% so) (P < 0.025) and the
priapism patients had a significantly elevated hct (33.9% + 4.5 SD)
when compared with the rest of their group (29.5% 4.7 SD) (P <
0.025). 2) Group 2 received i.v. iron, 40 to 100 m5/week; group
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I did not receive iv. iron. It appears that a hct over 30% in a
MHHP receiving continuing iv. iron and parenteral AT is asso-
ciated with a 20% risk of developing DP. The mechanism by which
this association may operate is uncertain. As the priapism always
presented on dialysis, an increase in blood ultrafiltration is sug-
gested as possible etiology.
Rehabilitation of Danish transplant patients. C. Frimodt-MØIler,
B. Nielsen, M. Bahnsen, Merete Balle, E. Clausen, S. Meilvang, J.
A. Nielsen, Kirsten Petersen, R. Snith Petersen, K. Roed-Petersen
and I. Steiness. A joint investigation by all Danish Nephrological
Centers. Prompted by an observed discrepancy between the overall
European rehabilitation figures and the degree of rehabilitation of
Danish transplant patients, a joint investigation of the working
ability of transplant patients was carried out. The influence upon
rehabilitation of the duration of illness, duration of posttransplant
period, age, sex, the patient's family position, educational and
social level and predialysis profession was evaluated. The high
level of social welfare and the ensuing acceptance of the sick
person's right to receive public economic support are presumably
the main factors that cause the percentage of patients back at
work after transplantation to be unsatisfactorily low.
Absorption, bioavailability and clearance of frusemide in chronic
renal failure. Adrian Fine, W. J. Ti/stone and A. C. Kennedy. Renal
Unit, Royal Infirmary, Glasgow, United Kingdom; and Department
of Forensic Science, School of Pharmaceutical Sciences, Stra:hclyde
University, Glasgow. This study was undertaken to determine a)
the absorption and elimination of frusemide (F) in advanced
chronic renal failure and b) the bioavailability of 500-mg tablets.
Previous investigators have found conficiting results that may be
attributable to the technical limitations of fluorimetric analysis of
F at low serum concentrations. Also'we have found that uremic
serum interferes with this assay method and we therefore used 35S-
frusemide in this study. Thirteen patients with GFR <5 mI/mm
were studied. 85S-F was administered both i.v. and orally to all
patients. Orally administered F was in the form of either
aqueous solution or 500-mg tablets. Results were calculated from
areas under curve from 0 —, 24 hr. In chronic renal failure, 57
of orally administered F was absorbed. There was a slight
but insignificant reduction of absorption with 500-mg tablets (42
12%). Renal elimination was negligible and approximated the
creatinine clearance. Extrarenal clearance was 20 6 mI/mm.
Thin-layer chromatography confirmed that the 35S-label in plasma
was representative of unmetabolized F. These results demonstrate
that in chronic renal failure approximately 50% of orally ad-
ministered F is absorbed and there is no reduction in bioavailabil-
ity is increased in uremia. Virtually no F reaches the urine to exert
its diuretic effect.
Effectiveness of 1-hydroxy and 25-hydroxy-vitamin D3 on bone,
calcium absorption and secondary hyperparathyroidism of patients
receiving repetitive hemodialysis. A. Fournier, P. Bordier, J. Gueris,
I. Chanard, J. Bedrossian, M. Ossario and H. deLuca. CHU
A miens and Hopitaux Lariboisiere, Necker, Broussais, Paris; and
College of Agricultural and Life Sciences, Madison, Wisconsin.
Four g of I -OH-D3 or 200 of 25-OH-D3 was given orally every
other day, respectively, to seven patients for eight to ten weeks and
to three patients for four to eight weeks. Before and at the end of
therapy were performed a transilial bone biopsy and serial evalua-
tions of serum immunoreactive PTH (iPTH), calcium (Ca),
phosphate (P04) and alkaline phosphatase (Pase). In the 1-OH-
D3-treated group, Ca increased significantly in five and P04 in four
cases. iPTH dropped significantly in four patients in whom os-
teoclast count (OC) and activity (OA) also decreased markedly. In
the three other patients, in whom iPTH remained unchanged, OC
and OA were stimulated and Ca increased. Osteoblastic surface
(SI), osteoid volume (OV) and Pase either dropped o, remained
unchanged. The calcification front (CF) increased dramatically in
two cases (110 to 220%) and moderately in the others. Fractional
absorption of 47Ca, measured in four patients, increased more in
the three anephric patients (100%) than in the remainder (20%). In
the 25-OH-D3-treated group, Ca increased and iPTH dropped
significantly in two patients (one anephric) whereas OC and OA
decreased. In the remainder, iPTH and Ca were unchanged and
resorption stimulated; P04 increased moderately. In contrast to the
l-OH-D3-treated group, there was an increase of Bl in all cases
and of Pase and OV in two cases. CF increased dramatically in the
anephric patient treated eight weeks and moderately in the two
others. Conclusion: Both l-OH-D3 and 25-OH-D3 (this latter,
however, at a dose 50 times higher) are able to depress hyper-
parathyroidism in two-thirds of the cases and to improve con-
sistently the defect of mineralization in dialyzed patients, whether
they are anephric or not.
"Weekly artificial kidney": Personal monitor with cartridge reuse.
P. Ghezzi. D. De Taddeo, P. L. Cavalli, R. Palanca and A. Rovere
(Intr. by M. Fusaroli). Servizio Emodialisi Ospedale S. Croce,
Cuneo (ha/ia) and DASCO, Mirandola (Italia). Cartridge reuse is
nowadays a very successful technique in hemodialysis centers as
well as in home dialysis. The economic advantage of reuse is quite
remarkable even in the case of reusing cartridges only once.
However, the procedures for the reuse are a source of possible con-
tamination for hepatitis and pyrogenetic reactions. Furthermore,
there is the problem of storing the sterilized and packed cartridges.
In order to reduce the work load and simplify preparation and
reuse, we have developed a simple "personal monitor" that permits
an automatic recovery of the cartridge, eliminating handling. In
our Unit this "personal monitor" has been used for 14 months
without any trouble and with a remarkable economic advantage.
By using the same cartridge two to three times for each patient, the
basic concept of "weekly kidney" is achieved.
The edematous phase of acute human glomerulonephritis is due to
the disappearance of a natriuretic factor which reappears during
recovery. Jean-Pierre Godon. Institut de Mêdecine, Universitè de
Liege, Liege, Belgium. In previous studies we have demonstrated
that the sodium retention observed in rats during the autologous
stage of experimental glomerulonephritis was due to the disappear-
ance of a natriutetic material (mol wt, 10,000 to 50,000) present in
urine and plasma of normal salt-loaded rats, this material being
tested by bioassay in normal rats receiving a normal salt diet (Ito
2 mEg of Na/day). We have pointed out that men with chronic
glomerulonephritis (as membranous proliferative glomerulone-
phritis) or nephrotic syndrome (with minimal changes) were un-
able, just as the diseased rats, to decrease overall fractional so-
dium reabsorption after saline loading. We have found that this
natriuretic material was present in urine and plasma of normal
salt-loaded men. This material is absent in plasma and urine of
men with acute or chronic glomerulonephritis and with nephrotic
syndrome with minimal changes. It reappears during the recovery
phase of acute glomerulonephritis and the nephrotic syndrome.
This demonstration is indirect proof for the existence of a natri-
Uretic factor (for which we have put forth evidence in other
studies) of renal origin. Its disappearance during experimental
or human glomerular disease is very probably the cause of renal
origin edemas. These results underline the importance of natri-
uretic factors for the regulation of sodium excretion in health and
diseases.
Single puncture dialysis without auxiliary equipment. Lars
Grimsrud, Norwegian Institute of Technology, Trondheim, Norway.
The single needle technique to permit hemodialysis through a
single entry into a blood vessel is becoming increasingly popular
even though it is encumbered with several drawbacks, such as
expensive auxiliary equipment, difficult adjustment procedures,
possibilities of blood recirculation and high necessary vessel blood
flow. By using a double lumen needle, the advantage of a single
puncture can be maintained whereas the drawbacks associated
with the ordinary single needle dialysis are eliminated. Such a
double lumen needle, with an 0.D. corresponding to a No. 14
ordinary needle, has been developed, and run clinically, both in
pediatric and adult patients. Continous blood flow up to 300
mI/mm is obtainable, with pressure drops of approximately 1 mm
Hg pr. nil/mm blood flow. No recirculation takes place as long as
the vessel delivers more blood than is being sucked out. At lesser
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vessel flows, recirculation automatically sets in, eliminating the
danger of vessel collapse. The puncture is made with a No. 17
needle, the diameter gradually expanding to a No. 14, stretching
the skin instead of cutting it. The puncture wound is thus smaller
than usual, facilitating sealing when the needle is withdrawn.
Clinical data to support the above will also be presented.
The place of the Sparks mandril in vessel access for hemodialysis.
D. N. H. Hamilton and I. D. Briggs. Renal Unit, Western infirmary.
Glasgow, Scotland. The Sparks mandril, a semi-artificial blood
vessel grown round a silicone rod, had originally been introduced
for dialysis patients with vessel access problems but can now be
considered as an alternative to established methods such as the
vein loop. In nine of ten patients, 6 mm mandrils have been suc-
cessfully inserted and used in the forearm, the preferred position
now being a long loop from the brachial artery at the elbow to the
basilic vein above the elbow. The one failure was immediate and
resulted from poor run-off through a small cephalic vein. Cannula-
tion is best carried out with standard needles, entry is easy and ex-
cessive bleeding does not occur. None of the nine functioning
mandrils have failed or shown aneurysm formation at up to six
months of use. The Mandril is preferable to the vein loop on ac-
count of its greater length; and in view of its success rate, we
therefore now insert and use a Mandril in patients whose
arteriovenous fistula has failed. Other advantages of the Mandril
are that it can be inserted under brachial block anesthesia or dur-
ing other incidental surgery. It can also be left indefinitely with the
rod in place, thus being available for immediate use for access
when required.
Undried cellulose gel film: A high permeability membrane for
dialysis. N. A. Hoenich, D. N. S. Kerr, J. C. Mackenzie and A. S.
Parker. Department of Medicine, University of Newcastle-upon-
Tyne; and Renal Unit. Southmead Hospital, Bristol. England.
Undried cellulose gel film (British Cellophane Ltd) has been as-
sessed in vitro. Results obtained indicate the membrane to be su-
perior in terms of ultrafiltration aod middle molecular clearance to
that of the widely used Cuprophan and comparable with that of
the Rhone Poulenc AN69 acrylopolynitrile membrane for middle
molecules but with a considerably lower ultrafiltration rate, en-
abling the membrane to be used with conventional dialysis equip-
ment. A full in vivo assessment is in progress, including measure-
ment of residual blood volume and red blood ceO and platelet
adherence and destruction; preliminary results show no disadvan-
tages compared with Cuprophan. Final results will be presented
at the meeting.
Comparative membrane clearance characteristics: blood flow:
200 mI/mm; dialysate flow, 530 mI/mm; temperature, 38°C
Im° Meltec Multipoint
RP.6
AN69
Membrane
BC
Undried
Cuprophan Cellulose
Urea
Creatinine
LJricacid
EDTA
Vitamin B2
Inulin
UF rateb
153 153
123 128
107 115
64 88
31 51
— 23
0.071 0.26
l33
ll3
—
52
58
25
0.62
° Dialysance.
mI/mm/mm Hg.
Quantitative assessment of renal transplant function on renogram
performed with Computer assisted gammacamera. Oei Hong- Yoe,
K. H. Ephraim, R. F. M. Jessururn, M. G. Nieuwenhuis and A.
Struyveitherg. University Hospital, Utrechi, The Netherlands. Cor-
tical ischemia and decrease of o-iodohippurate (Hippuran)
clearance during acute rejection is well documented. Consequently,
renal Hippuran accumulation within the first two minutes might be
a reliable indicator of kidney allograft rejection. With the patient
supine, at a fixed distance from a gammacamera, on-line with com-
puter, renography is performed. The dose of '°'I-Hippuran (D) is
measured with that camera. After correction of the renogram for
blood background, the integral of the first two minutes (N) is
determined. For calculation of Hippuran clearance (HC), blood
samples are taken at 2! and 35 mm. After analysis fo 200 examina-
tions, the authors report the following results: the two-minute ac-
cumulation ratio (AR) = N/D and is closely correlated with HC
but has, however, a better reproductibility than HC. AR decreases
during acute rejection or complications associated with deteriora-
tion of renal function such as urinary tract obstruction. Differen-
tiation between these two conditions is feasible by routine sequen-
tial scintiphotography simultaneously performed. The alteration of
AR during rejection is more reliable than "changes of the third
phase" of the renogram. in the case of prolonged oliguria, AR ap-
pears to show an increase on serial examinations before diuresis
occurs. Conclusion: AR is a valuable expression of renal function
which is not dependent on diuresis.
3-Adrenergic blockade reduces the severity of acute renal failure
(ARE) in rats. A. laina, S. Solomon and H. Eliahou (lntr. by J.Levy).
Department of Nephro/ogy, Sheba Medical Center, Tel Has/tome,,
Israel. The effectiveness of fl-adrenergic blockade in preventing
ARF in rats has been studied in the hypoxia model produced
by uninephrectomy and coritralateral renal artery clamping
for 70 mi Propranolol (P) was administered in saline for 100
mm at a rate of I mg/kg/hr beginning IS mm prior to clamping.
Blood urea and plasma creatinine were determined 24 hr later. In
seven control rats infused with saline alone, BI urea = 242 17.6
mg/lOO ml (mean ssM), P1 creat = 2.2 0.32 mg/lOO ml (N =
5). In P-treated animals BI urea = 108 20.3 mg/lOO ml (N =
6) and Per = 0.93 (N = 3). t-adrenergic blockade seems to be effec-
tive in reducing the severity of ARF in this experimental model.
Since /3-adrenergic blockade prevents release of renin, we have also
attempted to prevent ARF by treatment with a combination of P
and a synthetic angiotensin 11-competitive inhibitor (P1 13). No
further improvement was found. P urea was 107 19.7 mg/lOO ml
(N = 7) and Per = 1.1 0.12 mg/100 ml (N = 7). P113 alone was
unable to prevent or reduce the uremic state: Bi urea = 260 18.7(N = 7), Per = 2.8 + 0.33 mg/lOO ml (N = 5). The data can be
considered to be consistent with the view that it is the intrarenal
release of renin which is at least partially involved in the patho-
genesis of ARF.
Occult blood loss in chronic renal failure and its effect on iron
balance. K. M. Koch, P. B. Bechstein, W. Fassbinder, P. Kaltwasser,
W. Schoeppe and E. Werner. Department of Internal Medicine,
Frankfurt University, Gesellschaft fuer Strahlenforschung,
Frankfurt, West Germany. iron deficiency is assumed to play no
role in the pathogenesis of the anemia of the predialytic phase of
renal insufficiency. This is in contrast to studies proving reduced
intestinal iron absorption in chronic renal failure and our own
results demonstrating considerable occult blood losses in non-
dialyzed patients with renal insufficiency. In 38 patients with
chronic renal failure (mean creatinine clearance, 23 10 mI/mm
1.73 m2 so), by means of a whole body counter and radjoiron,
total daily blood loss (TDBL) and intestinal iron absorption (LIA)
from a test dose of Fe Il-sulfate were determined. Bone marrow
iron content (BMIC) was measured histochemically. The mean
TDBL (corrected for laboratory blood sampling of 4.3 2.6 ml
(Sn) was significantly (P < 0.01) higher than that of 1.0 0.0 ml
(so) in 16 normal controls. Only 40% of the patients had reduced
BMIC. Serum iron concentration, total iron binding capacity and
MCI-IC were normal. The mean hA of 40.6 + 18.3% (so) was sig-
nificantly (P < 0.01) higher than that of 30.2 10.8% (so) in 42
normal controls. The results prove the presence of a latent iron
deficiency caused by occult blood losses in nondialyzed patients
with chronic renal failure. An increase of these occult blood losses
as a consequence of heparinization with the onset of hemodialysis
may very well contribute to the increased iron demands of hemo-
dialysis patients.
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Plasma natriuretic activity in edematous states. H. J. Kramer and
F. KrOck. Medical University Poliklinik, Bonn. Germany. Ac-
cumulating evidence suggests that extracellular volume (ECV) may
be governed in part by a natriuretic hormone (NH). To study its
possible role in edema formation natiuretic activity was investi-
gated in six patients with the nephrotic syndrome (NS), six pa-
tients with cirrhosis of the liver (CL), and three patients with
idiopathic edema (IE) as compared to seven control subjects (C)
following ECV expansion with Ringer's solution. The effects
of plasma and plasma fraction IV isolated by gel filtration on
frog skin Na transport and rat renal Na excretion were studied.
Plasma and plasma fraction IV from C significantly inhibited
PD (44 6,22 4% and SCC (41 2, 18 3%) and, when injected
in the rat, increased urinary flow, C1,0 and UN V. Neither anti-
natriferic nor natriuretic activities were noted with plasma or
plasma fraction IV from NS or CL. In patients with IE, low Na
excretion (47 mEq/day) with fluid retention up to 8% of body
wt and spontaneous natriuresis (342 mEq/day) were well cor-
related with antinatriferic activity. The results suggest that ECV in
C may be governed in part by NH, which is absent in ECV expan-
sion due to edema in NS and CL. In contrast, this humoral
mechanism may operate appropriately, though at an elevated
threshold, in patients with IF.
Eighteen months' experience with a new vascular prosthetic device
(Sparks mandril) for periodic hemodialysis. Giuseppe La Greca,
Emanuele Botti, Stefano Biasioli, Ugo Coli, Aldo Fabris, P. Luigi
Gaianigo and Edmondo Pisani. Division of Nephrology, Ospedale
Civile, Vicenza. and 2nd Department of Surgery, University of
Parma, Italy. In a significant number of patients, blood vessels are
unsuitable for hemodialysis treatments. Using a mandril-grown
graft, we have obtained a satisfactory vascular access for repeated
venipuncture. The mandril assembly has been implanted s.c. in
nine patients with very serious vascular problems. Until now about
600 dialyses have been performed without complications by using
a single needle apparatus. In our series only one graft failed at the
end of seven months; it was replaced and its still functioning. Our
experience indicates that the Sparks mandri! method is very useful
for the problem of vascular access.
Globin synthesis in uremia. Heinrich- W. Leber and Georg SchOt-
terle. University Hospital, Giessen, West Germany. Our previously
published results have demonstrated that porphyrin metabolism is
altered in uremic patients. The present investigations were under-
taken to clarify whether the synthesis of globin is influenced by
uremic conditions. Periphereal blood cells from a) patients on in-
termittent hemodialysis, b) anemic patients with normal kidney
function and c) healthy subjects were incubated with an amino acid
mixture and labelled histidine. After an incubation period of two
hours, globin was isolated and the incorporation of labelled
histidine was measured. Despite severe anemia, blood cells from
uremic patients incorporated the same amount of histidine as those
from healthy subjects. The incorporation rate of histidine into the
globin moiety by blood cells from anemic patients differed depend-
ing on thc cause of anemia, but was significantly higher in patients
with acute blood loss or with hemolytic anemia. In uremic patients
no correlation existed between the activity of globin synthesis and
the plasma concentration of histidine. From our results it is con-
cluded: I) In uremic patients globin synthesis is not limited by the
amount of histidine supplementation. 2) Under uremic conditions
the rate of globin synthesis does not limit the synthesis of
hemoglobin.
Proliferation of smooth muscle cells in arteries of renal
transplants: Stimulated by extremely high dosage of corticoids? C.
Leithner, H. Sinzinger, 0. Wagner, W. Feigi, W. Pinggera, A. Wolf
H. K. Stummvoll and F. Piza. University of Vienna, Medical School,
Vienna, Austria. The donor and the recipient part of the
anastomosis of six acutely and five chronically rejected human
renal grafts were studied regarding the origin of smooth muscle
cells (SMC) and possible causes of their proliferation in the intima.
We used histochemistry, immunofluorescence (Anti-IgG, M, A,
C3, C4, fibrinogen) and electron microscopy. Each of four normal
Wistar rats received 20 mg of prednisolone i.v./day for one week
and I mCi of 3H-thymidine iv. one hour before killing. We ex-
amined the aorta with histochemistry, electron microscopy and
autoradiography. In the donor part of the arteries of the grafts, an
"activated" type of SMC with high metabolic and splitting activity
could be discerned from a "resting" type. All activated SMC
originated in the media and invaded the intima. Proliferation and
fiber production resulted in a thickening of the intima with a
decrease of the vessel lumen. Similar changes, but less marked, oc-
curred in the recipient part of the anastomosis in man as well as in
the aorta of the corticoid-treated rats. We assume that SMC were
stimulated by immunologic mechanisms of rejection, but also by
extremely high dose corticoids. This effect should be taken into
consideration.
Chemical properties of human glomerular basement membrane in
nephropathies with electron-dense deposits inside the basement
membranes. P. Mahieu and P. Galle (Intro, by J. P. Godon). Inst itut
de Mbdecine, Université de Liege, Belgium; et Laboratoire de
Biophysique, Faculté de Médecine, Créteil, France. Glomerular
basement membranes have been isolated from five kidneys of
patients suffering from nephropathy with electron-dense deposits
inside the basement membranes. After isolation, as well as in situ,
these membranes were irregularly thickened and contained the
electron-dense material. The presence of this material could not be
accounted for by the accumulation of bound 'y-globulin or col-
lagen. Normal and abnormal membranes exhibited the same car-
bohydrate and amino acid composition. However, the diseased
membrane exhibited a significant decrease in its cystine content
and a significant increase in its sialic acid content. There was no
significant modification in the amount of hydroxylysine, hydrox-
yproline or glycosylgalactosyl-hydroxylysine units in abnormal
membranes. The data suggest that the electron-dense deposits
observed in glomerular basement membranes of these
glomerulonephritic kidneys are the consequence of the accumula-
tion of a glycoproteic material slightly different from that normally
present.
Improved phosphorus binder for hyperphosphatemia prevention in
patients receiving dialysis. N. K. Man, A. Becker, T. Drueke, J.
Zingraff, P. Jungers and J. Crosnier. Hopital Necker, Paris, France.
Oral administration of aluminium salts is the method widely used
to prevent hyperphosphatemia in patients receiving regular dialysis
treatment. Agents currently used are antacid preparations which
are not optimised for phosphorus binding action. Our purpose is to
define an aluminium hydroxide (AH) with high phosphorus
binding capacity (PBC) without side effects, such as nausea and
vomiting, for the patients. An experimental AH of
macromolecular structure is tested and compared to several agents
commercially available. In in vitro studies, the maximum PBC of
conventional AH, an aluminum carbonate gel (Basalgel Suspen-
sion) and the experimental AH are in average 40, 110 and 250 mg
of phosphorus/g of binder, respectively. Balance studies in five
patients receiving dialysis show an increase in fecal excretion ol
phosphorus while the test substance is being administered (in a
small dosage) when compared to conventional AH. These results
suggest that the experimental AH could be a reliable phosphorus
binding agent in the prevention of hyperphosphatemia in patients
receiving regular dialysis treatment, Its use could be extended to
patients with chronic renal disease for control of phosphatemia.
Short-time dialysis. T. Manji, K. Maeda, K. Ohta, A, Saito, A.
Amano, S. Kawaguchi and K. Kobayashi. Nagoya University Branch
Hospital and Chukyo Hospital, Nagoya, Japan. A previous report
on asymptomatic short-time dialysis was presented before the
EDTA, 1974. Increased blood flow and membrane area would be
required to shorten dialysis time without sacrificing efficiency. For
the purpose of effecting dialysis without any side effects, we have
reduced the fluctuation in serum Osmotic pressure in short-time
dialysis, employing a recirculation system with the dialysate osmotic
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pressure at 290 mOsm. Short-time dialysis has been conducted in
two ways. I) In using the 2.5 m2 I-IFK with absorbents, 10 liters of
dialysate has been recirculated. All through the eight months of
four-hour dialysis thrice weekly with this method in which pre-
dialysis BUN and Hct stood at 90 to 100 mg/lOO ml and 25% each,
no side effects were seen, leading to complete rehabilitation with-
out fatigue. 2) Two patients have been treated on the ASAHI
JUMBO HFK, one on three-hour dialysis for two years thrice-
weekly (body wt, 49 kg), and the other on four-hour dialysis for
one year thrice-weekly (73 kg). In this U-shaped HFK, ultra-
tiltration is effected' by a positive pressure, with a dialysate flow
at 8 liters/mm welling up from the bottom center. Placing ad-
sorbents and HFK in parallel in the dialysate tank seems indica-
tive of another step toward miniaturizing and materializing a
compact, portable artificial kidney. In the short-time dialysis, our
patients were completely rehabilitated in terms of general condi-
tion. Thus, it is obvious that membrane area can be increased and
the dialysate recirculated at high osmotic pressure for greater effi-
ciency in asymptomatic short-time dialysis.
Lymphoceles in renal homograft recipients. A. Meyers, D.
Salant, I?. Rabkin, J. Mi/ne, R. Botha andJ. Myburgh. University of
Wit watersrand, Johannesburg, South Africa. Seven lymphoceles
have complicated 158 cadaver and 18 RLD transplants performed
over six years. The purpose of this study is to review the clinical,
diagnostic and therapeutic problems encountered with
lymphoceles at this center. Presentation was insiduous, delayed (50
days postoperatively), and manifested by one or more of the fol-
lowing: palpable rectal or suprapubic mass; unilateral leg edema;
recurrent urine infections with radiographic evidence of obstruc-
tion; filling defect in bladder on routine IVP. Possible pathogenetic
factors were: transplants performed on side of functioning Schrib-
ncr shunts (six of seven cases); severe rejection episodes with graft
lymphatic leak (one of seven cases). Differentiation from
urinomas, hematomas, perinephric abscesses or other causes of
obstetrical uropathy were facilitated by: needle aspiration; JVP and
cystogram, serial ultrasound sonography. Lymphangiography was
not used. Treatment was conservative in three, repeated aspira-
tions were performed in two and formal drainage procedures were
required in three patients. Repeated cyst aspiration resulted in
serious infections in both patients. Marsupialisation into the
peritoneal cavity failed in one. Conclusions: I) Grafts should be
anastomosed on the side opposite a functioning shunt. 2)
Lymphoceles have an occult presentation and should be actively
sought for as they may produce urinary obstruction. 3) Serial
ultrasound is an excellent method of diagnosis and follow-up. 4)
Unless urinary obstruction is present, management should be con-
servative as spontaneous resolution may occur. 5) Ideal surgical
management is problematical. Repeated needle aspirations should
be approached with caution.
Gastrin and gastric secretion in chronic renal failure (CRF). F.
Mignon, J. P. Galmiche, J. P. A ccary and M. F. Mignon. Depart-
ment of Nephrology (Pr Richet). Hopital Tenon, INSERM U 10 (Pr
Bonfils), Paris, France. Hypergastrinemia noted in patients with
CRF is thought to be mainly related to loss of renal function; in-
creased production and/or release of endogenous gastrin has been
discussed but not evaluated. Fifteen CRF male patients, aged 21 to
66 yr, with serum creatinine from 5.0 to 18.0 mg/lOO mg were
studied using the OXO test to assess antral gastrin functional mass:
in this test plasma gastrin (PG) and acid output (AO) are measured
repeatedly for 100 mm after intragastric instillation of a 100-mI
solution of meat extracts at pH 7 and compared to fasting values.
For comparison, 18 men with duodenal ulcers (DU), aged 28 to 56
yr, were studied accordingly. In both CRF and DU, AO and PG
were increased after OXO compared to fasting values (P < 0.01).
No difference exists between the two groups in respect to acid
responses to OXO. Although mean fasting PG are not different in
the two groups, the mean gastrin response to OXO expressed as in-
tegrated gastrin response (IGR given as pg/I 10 mm) is larger in
CRF than in DU, P < 0.05 (Mann-Whitney U test). Although no
correlation could be f'ound in CRF between AO and JGR after
OXO, in five patients a significant increase in PG is associated with
a large increase in AO (from 40 to 90% of the maximal AO to pen-
tagastrin). These results indicate that in CRF antral stimulation
may induce a significant increase in AO and PG and suggest that
measurement of gastrin and acid responses to the antral function
test should be included in the gastric assessment of prospective
renal transplant patients.
On the pathogenesis of acute renal failure due to rifampicin (R-
ARF): Clinical and histological observations in four patients. L.
Minetti, G. Barhiano di Belgiojoso. G. Civati, A. Durante, A. Scatizzi
and M. Surian. Divisione di Nefro/ogia, Ospedale Maggiore Ca
Granda, Milano, Italy. R-ARF is one of the few drug-induced
nephropathies for which the responsibility of the drug maybe con-
firmed with certainty. Nevertheless, the mechanism of renal injury
is still controversial; some data suggest vasomotor nephropathy,
some suggest hypersensitivity nephritis. In four patients at secon-
dary exposition to the drug we have observed five episodes of ARF.
Indeed, one patient who resumed taking rifampicmn after seven
months presented again with ARF with the same clinical pattern.
All cases were treated with dialysis and recovered normal renal
function. The earlier clinical manifestations were consistent with
anaphylactoid reaction; some late manifestations were like the al-
lergic vasculitis type clinical pattern. Neither important hemolysis
nor arterial hypotension was observed. In two cases reagins were
looked for and very high serum levels of IgE, then rapidly re-
gressed, were found. In the three biopsied patients, the tubular and
interstitial changes supported the diagnosis of acute ischemic
('vasomotor') nephropathy, but other findings as arteriolar lesions,
composition of interstitial cellular infiltrate, and above all, im-
munohistological evidence of C3, Clq and C4 (scarcely of lgG and
lgD) on arterioles, mesangium and tubular basement membranes
suggested also the local involvement of an immunological
mechanism. The mechanism by which the reaction between the an-
tigen and the specific antibodies produces renal acute ischemic in-
jury is at present only conjectural. Maybe, in R-ARF renal
vasomotor effects of anaphylactoid reaction prevent or blunt the
local development of immunological processes.
Serum lipids and lipoproteins in acute renal failure. M. Mydlik, 1.
Ahiers, K. Derzsiovb and M. Takâè. 1st Department of Internal
Medicine and Department of General Biology, Safàrik University,
Kotice, Czechoslovakia. Fifty-one patients with various forms and
phases of acute renal failure without and with hemodialysis treat-
ment were investigated. The concentrations of free fatty acids
(FFA), triglycerides (TG) and total cholesterol (CH) in serum were
determined; separation of lipoprotein classes on agarose gel was
performed. Increase in FFA and TG and decrease in CH con-
centration in serum characterized the anuric phase. Decrease in
FFA and TO and increase in CH concentration was observed as a
regular effect of hemodialysis treatment. A decrease in prebeta and
increase in beta lipoprotemn fraction proportion immediately after
the termination of hemodialysis occurred. In the polyuric phase of
acute renal failure, simultaneously with improvement of clinical
signs there was a significant decrease in FFA and TO and increase
in CH concentration in serum. In the course of the convalescence
phase, an increase in prebeta and decrease in beta lipoprotein frac-
tion proportion was noted, despite of adverse trend of serum TO
and CH concentrations.
Influence of potassium and ACTH in the regulation of plasma aldo-
sterone in anephric patients. K, flgaard and S. Madsen. Medical
Department P Rigshospitalet, Copenhagen, Denmark. In seven
anephric patients receiving regular hemodialysis a significant cor-
relation between changes in plasma aldosterone and plasma potas-
sium was shown. Presuming that the administration of insulin-
glucose increases the intracellular concentration of potassium in
the adrenals without changing the total potassium balance, plasma
aldosterone was measured in the same patients following in-
fusion of insulin-glucose. The plasma aldosterone increased
significantly to 180% of the preinfusion value. An inverse sig-
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nificant correlation between the changes in plasma potassium
and plasma aldosterone was found. Furthermore, six anephric pa-
tients received iv. ACTH stimulation. All patients showed simul-
taneously a significant increase in plasma cortisol and plasma
aldosterone concentrations. These studies indicate that in anephric
patients changes in the plasma potassium concentration, via
changes in the intracellular potassium level, as well as
ACTH stimulation are important regulators in aldosterone
secretion.
Migration of plasticizer from hemodialysis blood tubing. Keiji
Ono, Ryo Tatsukawa and Tadaaki Wakimoto. Fukuoka Municipal
Daiichi Hospital. Fukuoka, and Ehime University, Matsuyama,
Japan. Di-2-ethylhexyl phthalate (DEHP) plasticizer was found to
be migrating from polyvinyl chloride (PVC) blood tubing into
human blood during hemodialysis in 16 patients with end-stage
renal failure by gas chromatography. The blood level of DEHP in-
creased during in vivo hemodialysis up to 389 ppb. However, the
DEHP level decreased again toward the end of the six-hour dialysis
period. During in vitro hemodialysis of human blood, DEHP ac-
cumulated in the blood up to 509 ppb. Compared to the DEHP
level, there was a significant accumulation of phthalic acid, which
is the common structure of DEHP and its metabolites in blood in
vivo and in vitro hemodialysis. These results indicate that migrated
DEHP from PVC tubing during hemodialysis is metabolized or
taken up by a variety of tissues and is removed by the next period
of hemodialysis. Although toxic effects from this material have not
yet been reported in patients receiving hemodialysis, we feel that
plastic nateriais which do not contain additives that will migrate
during dialysis should be available.
Polymethylmethacrylate capillary kidney highly permeable to
middle molecules. Kazuo Ota, Tsutomu Okazawa, Tetsuzo Agishi,
Eiji Kurnagaya, Naoyuki Mitani and Hiroshi Tanzawa (Intr. by Ken-
jt Maeda). Kidney Center, Tokyo Women's Medical College, Tokyo,
Japan and Toray Industries, Inc., Kamakura. Japan. Based on up-
to-date knowledge, dialysis with a membrane highly permeable to
middle molecules is recommended to remove uremic toxins. For
this purpose, a capillary kidney, which utilizes a completely new
material, polymethylmethacrylate (PMMM. as a dialysis
membrane and has high flux of ultrafiltrate, has been developed.
The performance and characteristics of this new membrane
dialyzer are as follows: 1) A PMMA capillary kidney is composed
of 8000 PMMA capillaries and has the surface area of 1.35 m2. 2)
Dialysance spectrum (mean): urea, 150 mI/mm; creatinine; 125
mI/mm; uric acid, 97 mI/mm, vitamin B12, 47 mI/mm; and insulin,
33 mI/mm (QB = 200 mI/mm, Q = 500 mI/mm). 3) Ultrafiltra-
tion rate is 19 ml/min/lOO mm Hg. 4) Washout of formalin is much
easier than in the Cordis Dow M4. All ten volunteer patients on
this new membrane dialyzer have been in satisfactory condition.
Long-term therapy with 1.25 (OH)2CC in dialysis bone disease.
A. M. Pieria'es, M. Ward, F. Alvarez- Ude, H. A. Ellis, K. M. Pearl,
W. Simpson, D. N. S. Kerr and A. Norman. Newcastle-upon-Tyne,
England; and Riverside, California, U.S.A. This study was under-
taken to assess the effect of long-term, low dosage therapy with
1.25 (OH)2CC in patients with dialysis bone disease, Five patients
receiving regular hemodialysis with severe osteomalacic bone
disease—confirmed by bone histology and resistant to previous
treatment with CaCO3, AI(OH)3 and dihydrotachysterol—were
studied before and after treatment with 1, 25 (OH)2 HCC 1, 1.5
pg/day for six months. All patients had malabsorption of calcium
as measured by a two-hour 47Ca absorption test, but when reex-
amined after two to four weeks' treatment they showed significant
improvement. Biochemical assessment showed a gradual return of
serum alkaline phosphatase to normal, and hypercalcemia was no
problem. Radiologically there was healing of pathological frac-
tures and resolution of secondary hyperparathyroidism. Clinical
myopathy improved and the results of quantitative elec-
tromyography are awaited. The effect on quantitative bone
histology will be reported. I, 25 (OH)2CC is a safe and effective
drug in the management of patients with dialysis bone disease.
Serum lipids in uremic patients receiving regular hemodialysis.
A. M. Pierides, D. Weigh tman. M. Goldfinch, T. Tsoukantas and
D. N. S. Kerr. Newcastle-upon-Tyne, England. Seventy-five regular
hemodialysis patients were assessed as to fasting serum
triglycerides (TG), cholesterol (chole), lipid electrophoresis, indices
of obesity, length of uremia and time on regular hemodialysis.
These patients were compared to normal people from the same
local area. Significant changes in lipid metabolism were present in
the hemodialysis patients. Differences between male and female
hemodialysis patients were also noted. Male hemodialysis patients
showed higher TG levels than normal people and these differences
were significant in the age groups 17 to 24 yr (P < 0.01) and 25 to
34 yr (P < 0.05). In contrast, cholesterol values were not generally
raised but reached their peak a decade earlier than in normal peo-
ple, and in the age group 45 to 54 yr, they were significantly lower
(P < 0.05). TG correlated with % body fat, r = 0.39 16 (P < 0.01);
length of uremia, r = 0.3506 (P < 0.05); and time on hemodialysis,
r = 0.3790 (P < 0.02). Female patients also showed elevated TG
values but only significantly higher in the age group 17 to 24 yr (P
< 0.01). Cholesterol values were generally raised reaching signifi-
cance in the age group 45 to 54 yr (P < 0.00 1). Compared to male
patients, female patients had significantly higher cholesterol values
(P < 0.01) and lower TG (P < 0.05). There was no correlation
between their serum TG and cholesterol and % body fat, length of
uremia and time on regular hemodialysis.
Lipidic pattern in hemodialyzed and transplanted patients. C. Pon-
ticelli, G. Barbi, G. Mecca, A. Cantaluppi. G. Annoni, F. Mauri and
D. Brancaccio. Sez. Nefrology, Ospedale Policlinico, Milano,
Clinica Medica III, Universit2, Milano and Division of
Nefrolology, Bergamo, It aly. In 103 patients receiving RDT
(dialysis age, 1 to 96 months; mean, 24) and 57 transplant (Tx)
patients (Tx age, 1 to 73 months; mean, 17), fasting blood
cholesterol, triglycerides, pre-/3- and 3-lipoproteins were signifi-
cantly higher than in normal age-matched controls. Only 32% of
dialyzed patients and 42% of Tx patients showed a normal lipidic
pattern; in the others the prevalent disorders were type lib and
type IV hyperlipidemias, pathological conditions which, per se or
in combination with other factors, can predispose to accelerated
atherosclerosis. Since pharmacological treatments of these dis-
orders are often unsuccessful, a small group of patients was sub-
mitted to a hypocaloric (1700 Cal) and hypoglycidic (130 g) diet.
The lipidic pattern was normalized and maintained in the normal
range for the period of observation (two to ten months). In order
to prevent atherosclerosis, such a dietetic treatment could be sug-
gested to patients exhibiting severe hypertriglyceridemia.
Results of long-term treatment of patients with uremic os
teodystrophy with I-a-hydroxy-cholecalciferol. S. Pors Nielsen, E.
Binderup, W. 0. Godtfredsen, H. Jensen and J. Ladefoged. Three
adolescents receiving regular hemodialysis were treated for one
year with daily oral doses of I-a-hydroxy-cholecalciferol (0.25 to
10.0 g). Aluminium amino acetate, 8% (15 ml X two to four), and
Ca gluconate (500 mg of Ca/day) were given during the treatment.
All the patients were hypocalcemic and had high serum levels of
alkaline phosphatase before the treatment. Two of them had severe
uremic osteodystrophy with gross bone deformities. A rapid rise
in serum calcium and a slow but pronounced decline in serum
alkaline phosphatase concentration were observed during the
period of treatment. The response did not subside during the treat-
ment. On the contrary, the maintenance dose necessary to keep
serum calcium Constant was smaller than the initial dose necessary
to normalize serum calcium. Bone mineral content, estimated by
photon absorptiometry, rose, and the rachitic bone lesions seen
radiologically were significantly ameliorated during the treatment.
Effect of indomethacin (INDO) on plasma renin activity (PRA
in man. K. W. Rumpf, S. Frenzel, H. D. Lowitz and F. Scheler. Divi-
sion of Nephrology, Department of Internal Medicine, University
Hospital. Gittingen, Federal Republic of Germany. There is some
evidence that depressor prostaglandins (PG's) might be of signifi-
cance for normal blood pressure regulation. However, suppression
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of the PG synthesis by INDO does not lead to a consistent blood
pressure elevation. This might be explained by lowered PRA. We
therefore measured PRA in 28 volunteers before and after INDO.
The influence of stimulation of PRA by orthostasis or frusemide
was tested. PRA was measured by radioimmunoassay. In control
experiments PRA was 3.3 ng/ml/hr. After INDO PRA was
depressed to 1.6 ng/ml/hr. The response of PRA to stimulation by
orthostasis or frusemide was also diminished. Control values of 6.7
ng/ml/hr after orthostasis and 11.7 ng/m 1/hr after frusemide were
measured. INDO lowered these values to 2.6 ng/mi/hr and 5.0
ng/mi/hr, respectively. These results show a possible interaction of
the renin-angiotensin system and depressor PG's. The mechanism
of the depression of PRA and its diminished stimulation after
INDO is discussed. Experiments to elucidate this mechanism are
presented.
Nitrogen metabolism change in dialysis patients treated with a 10-
liter dialysate supply system with adsorbents. A. Saito, K. Maeda, S.
Kawaguchi, K. Kobayashi and K. Ohta. Nagoya University Branch
Hospital and Chukyo Hospital, Nagoya. Japan. We administered
long-term hemodialysis to 50 patients with a 10-liter dialysate sup-
ply system with 500 g of activated charcoal and 200 g of alumina.
General conditions of all the patients were maintained in well-
being. We were interested in the fact that in spite of low reduction
rates of urea with this system, actual predialysis BUN levels in
these patients were low enough (50 to 70 mg/lOO ml). These pa-
tients had a protein intake of 70 g/day and were not on a low pro-
tein diet. Nitrogen balance studies and amino acids analysis were
done and '5N-urea, lg, was administered iv. to four of these
patients. '5N atom % excess of plasma protein was 0.362 0,052 at
the highest points and showed higher rates compared to those in
the patients on dialysis with a single pass system. Large amounts of
urea N in these patients were incorporated into plasma protein. It
is supposed to be a physiological adaptation resulting from dialysis
with lower dialysis efficiencies in relation to reduction rate of urea
compared to those of other nitrogen metabolites. Thus, it is possi-
ble to reduce dialysate volume by utilizing this physiological adap-
tation and not by forcing urea reduction.
Polymorphonuclear leucocyte function in chronic renal failure and
after renal transplantation. D. Salant, A. Glover, R. Anderson, A.
Meyers, R. .Rabkin, J. Myburgh and A. Rabson. University of
Wit waters rand, South Africa. The tendency of patients with
chronic renal failure and after renal transplantation to develop
bacterial infection prompted us to assess polymorphonuclear
leucocyte (PMN) function in patients with chronic renal failure
receiving conservative therapy, in others receiving regular
peritoneal or hemodialysis, and in a group of patients who had
received renal allografts. Neutrophil chemotaxis, phagocytosis and
bactericidal ability was tested in vitro and compared to a group of
normal controls. The ability of patients' PMNs to move towards
normal endotoxin activated serum and the ability of activated
patients' serum to generate chemotaxis using normal PMNs was
assessed in a Boyden chamber. PMN phagocytosis was tested by
the ingestion of Candida albicans in the presence of fresh AB
serum. Bactericidal ability was studied using Staphylococcus aureas.
A severe defect in the ability of patient PMNs to move towards a
chemotactic stimulus was found in all four groups of patients
tested but was most marked in the group receiving regular
hemodialysis. A decreased ability of patient serum to generate nor-
mal chemotactic factors was observed in all four groups. PMN
phagocytosis was normal for patients of all groups. Although oc-
casional patients had depressed killing activity, there was no
significant difference between any of the groups and the controls.
Chemotaxis was markedly impaired in the groups tested and could
predispose to infection.
Comparison of two strategies for short dialysis, using 1 m2 and 2
m2 surface area dialyzers. S. Shaldon, P. Florence. P. Fontanier, C.
Poliro and C. Mion. Service du Traitement de l'Insuffisance Rénale,
Montpellier, France. Short dialysis offers more efficient utilization
of dialysis facilities and reduction in cost. Large surface area (2 m2)
dialyzers often produce hypovolemic symptoms, causing signifi-
cant patient discomfort. A trial of! m2 dialyzers (Gambro Lundia
l3.5z, single use) 5 hr trice-week in 13 patients during one year
was performed (group I) to see if patient comfort was improved
without appearance of signs of inadequate dialysis. The results are
compared with a trial of 2 m2 dialyzers (2 Gambro Lundia 1 7t in
series, reused eight times) for 4½ hr thrice-weekly on 12 patients
during two years (group ii). Both groups were dialyzed with com-
parable QB, 200 to 250 mI/mm, and QD, 500 mI/mm; and were
matched for age, sex, body wt, blood pressure and dietary control.
Hypovolemic symptoms (judged by the need for saline infusions)
occurred in 30% of group I dialyses and 54% of group II. Mean
Het was 25% in group I and 24% in group Ii. Both remained un-
altered during the trial. Mean nerve conduction velocity—group I,
46.3 m/sec, and group II, 45.5 m/sec—remained stable. Mean
predialysis serum phosphate—group I. 6.1 mg/lOO ml, and group
Il, 6.9 mg/l00 mi—was not significantly different. Short dialysis
with a I m2 dialyzer offers fewer complications than with a 2 m2
dialyzer. Clinical health and adequacy of dialysis appeared com-
parable in the two groups, suggesting that the middle molecule
theory is no longer tenable in its present form, or that reusing large
surface area dialyzers reduced their efficiency progressively.
Portable/wearable artificial kidney (WAK): Initial evaluation.
R. L. Stephen, S. C. Jacobsen, Elisabet A (kin-Thor and W. J. Koiff.
Division of Artificial Organs, University of Utah, Salt Lake City,
Utah, USA. This report discusses the modus operandi and results
achieved using this new mode of hemodialysis. An insulated 20-
liter dialysate bath acts as a carrying case for the system. When
empty the case is large enough to hold the wearable module and
complete supplies for one week's operation—total weight: 17 kg.
The wearable unit consists of a combined blood and dialysate
pump (1.2 kg), rechargeable batteries, tubing, Dow dialyzer and
charcoal regeneration module, total weight, 3.5 kg. Ideally the
patient dialyzes (single needle) some three hours/day, six
days/week. It is necessary that the wearable module be connected
to the 20-liter dialysate bath for an average cumulative time of 90
mm to achieve adequate urea and K removal. One patient was
dialyzed 35 consecutive days and four others were dialyzed inter-
mittently. Routine laboratory tests and mass balance studies were
performed on all patients. Ultrafiltration rates reached 700 ml/hr,
routine serum chemistries remained stable and mass balance
studies demonstrated daily removal of urea, 14 to 20 g; creatinine,
1500 to 2000 mg; uric acid, 500 to 900 mg; and KF, 30 to 55 mEq.
It is concluded that daily dialysis with the WAK is biochemically
adequate and also permits the patient a much less restricted ex-
istence.
Transplant monitoring: Patterns of the immune response. C. R.
Stiller, N. R. Sinclair, R. A. Ulan. El. McGirr, W. T Howson, S.
Abrahams and J. Sing/i. Nephrology and Transplantation Unit,
University Hospital, London, Canada. Monitoring with seven assay
systems the immune response in 26 graft recipients over 184 pa-
tient months indicates that the presence of cell-mediated
lymphocytotoxicity (CML) against donor spleen cells is associated
with and predictive of classical acute rejection. In the same series of
patients, the presence of lymphocyte-dependent antibody (LDA)
cytotoxic to donor spleen cells was observed in a number of rejec-
tions. LDA not absorbable by platelets (non.HL-A directed) has
been associated with a quiescent transplant course and may serve a
protective function. In other patients, LDA is associated with re-
jections and appears to represent a damaging effector mechanism.
Antibody capable of inhibiting the unidirectional mixed
lymphocyte culture (UMLC) of the recipient against donor spleen
cells was found in recipients' serum during rejection episodes and
may indicate an ineffective control rather than actual graft
enhancement, or may reflect humoral immunity. Although a
similar pattern of in vitro responses occurred in the first 14 days in
all recipients, following this each individual attained a constella-
tion of immune responses unique to that individual, variations
from which resulted in changes in the clinical course.
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Induction of specific immunological tolerance to histoincompatible
renal and skin allografts after donor strain spleen implantation. R. N.
Taub, H. Schanzer and J. Bramis. Transplantation Immunology
Laboratory, Mount Sinai School of Medicine, New York, New
York, U.S.A. Spleens from Lewis X BN Fl hybrid rats were
directly anastamosed to the circulation of parental Strain Lewis
rats by a microvascular technique; no immunosuppressive drugs
were given. Donor spleens enlarged massively during the first
month after implantation, then grew gradually smaller over suc-
ceeding months without compromising their blood supply. Renal
allografts were placed into bilaterally nephrectomized recipients
that had already borne a splenic allograft for three months. These
grafts functioned perfectly and showed no signs of rejection five
months later. Donor LBN skin allografts transplanted to these
animals showed markedly prolonged survival while third party
BUF rat skin allografts were rejected in first-set fashion. High
titers of anti-LBN hemagglutinating antibody could be detected in
the circulation of spleen-grafted animals during the first month; the
titers fell to zero by the fourth month. Cellular reactivity of
recipient cells against LBN antigens measured by the popliteal
node GVH assay fell to minimal levels by the third month. These
data indicate that the immune response to allografted tissues may
be specifically and markedly suppressed in adult animals by the
continued presence of a donor-strain spleen.
Effect of organ preservation in cadaver kidney transplantation.
L. H. Toledo-Pereyra, R. L. Simmons, A. W. Moberg, T. J.
Busel,neier, C. M. Kjellstrand and J. S. Najarian. University
Hospitals, Minneapolis. Minnesota, U.S.A. Terasaki reported that
32% of 805 cadaver kidneys (from 108 institutions) preserved by
hypothermic pulsatile perfusion had to be removed within one
month after grafting. Contrary to his results, we removed only 3%
of 147 consecutive perfused cadaver kidneys within the first month
of grafting. To further assess the effect of perfusion on immediate
and long-term organ function, the actuarial survival of all (1968
through 1973) fresh cadaver, nonperfused kidneys (79) was com-
pared at three years with the survival match, kidney loss, warm and
cold ischemia, recipient age, renal disease and acute tubular
necrosis. Operative technique, immunosuppression regimen and
postoperative treatment remained otherwise unchanged. Com-
paratively, there was a 20% better overall three-year functional sur-
vival of perfused kidneys (103/147 = 79%) vs. fresh kidneys (40/79
= 50%). In 1971 a prospective randomized comparative study
analyzed 37 kidneys (10/20 = 50% nonperfused vs. 12/17 = 70%
perfused). There was also a 20% better survival of the perfused
kidneys three years later. These results confirm the better long-
term outcome of perfused vs. nonperfused kidneys. We found no
difference in tissue match between perfused or nonperfused
kidneys, nor was there any difference in length of warm ischemia,
recipient age, type of renal disease, or even in posttransplant acute
tubular necrosis. Our three-year survival for perfused kidneys is as
good as Terasaki's reported one-month survival. Perfusion for 24
to 48 hr does not adversely affect long-term renal allotransplant
function and continued use of this technique is indicated.
Relationship of glomerular filtration rate (GER) and hy-
poalbuminemia to renal glucose reabsorption. M. Usberti and V. E.
Andreucci. Division of Nephrology, Second Faculty of Medicine,
University of Naples, Italy. Micropuncture studies in rats and dogs
indicate that Starling forces play a main role in regulating proximal
tubular reabsorption (PTR). If this effect is obtained in man,
hypoalbuminemia in the nephrotic syndrome should lead to a fall in
PTR of sodium that is offset by distal overreabsorption. Glucose
may be used as a marker of PTR. It has been shown, in fact, that
reabsorption of glucose is linked to that of sodium. Since the
former is limited to proximal tubule, it is expected to be suppressed
when PTR of sodium is suppressed. Glucose titration studies were
performed in normal subjects (control) and in edematous patients
with the nephrotic syndrome (serum albumin < 2 g/100 ml) with-
out renal failure. Maximal rate of glucose transport (Tm) ap-
peared to vary directly and linearly with GPR. The minimum
threshold for glucose decreased in nephrotic patients and its fall
was related to hypoalbuminemia rather than to GFR. These data
support the hypothesis that Starling forces regulate glucose reab-
sorption and are consistent with a decrease in PTR in the nephrotic
syndrome.
Combined hemodialysis-charcoal hemoperfusion in the dialysis
patient. James F. Winchester, J. M. Mackay and A. C. Kennedy.
University Department of Medicine, Royal Infirmary, Glasgow,
Scotland. The study was designed to assess the short-term effects of
combined hemodialysis/activated charcoal hemoperfusion on the
biochemical, hematological and clinical status of the uremic
patient. An activated charcoal hemoperfusion device developed by
Smith & Nephew Research Limited, U.K., originally for treatment
of drug overdosage was placed in series with standard
hemodialyzers, blood flow rates being maintained at 300 mI/mm.
Hemoperfusion was continued for a two-hour portion of a five-
hour dialysis schedule and resulted in a 30% increased removal of
both uric acid and creatinine, with very little increase in urea
removal. During combined hemodialysis/hemoperfusion,
creatinine clearances and uric acid clearance were increased by 100
and 50%, respectively. Medium molecular weight substance
removal during hemodialysis, and the effect of additive hemoperfu-
sion, was also studied. There were significant but not unacceptable
falls in blood platelet concentrations and some alteration in
coagulation factors. The device is efficient in terms of creatinine
and uric acid adsorption and with suitable modification may be
useful in reducing dialysis time.
Acute renal affect of new beta blockers on renal function. P. Zech.
N. Pozet, M. Labeeuw, J. Bernheim, M. Pellet and J. Traeger. Cli-
nique de nephrologie, hopital Ed. Herriot Lyon, France. (3-blockers
are efficacious antihypertensive drugs. The decrease of glomerular
filtration rate (GFR) and renal blood flow (RBF) is one of their un-
desirable effects, especially in cases of chronic renal failure. Direct
iv. acebutolol (AB) (25 mg) was injected in 32 patients. Thirty-mm
infusion of ICI 66082 (ICI) (15 mg) was performed in 40 other
patients. Four groups of patients were studied: I, with inulin
clearance (l.Cl) > 70 mI/mm; II, between 30 and 70 mI/mm; Ill.
10 to 30 mI/mm; IV, < 10 mI/mm. In two control periods oF 30
mm before and four hours after the injection, I. Cl, PAH (PC),
urea (UC), creatinine (CC), and uric acid clearances were studied.
Na, K, Ca, P and urine excretion (UE) were analyzed during the
same periods. After AB injection a decrease of 13% of 1. Cl, 18% of
PC, 38% of CC, 50% of UC and 46% of diuresis was observed. A
decrease of 50% of NaUE appeared in groups I and II, of 25% in
group III and of 20% in group IV. After ICI infusion a decrease of
12% of I. Cl, 13% of PC, 48% of CC, 24% of UC and 40% of
diuresis was observed. A decrease of 53% of NaUE appeared in
groups I and II, of 27% in group HI and of 20% in group IV. A
decrease in GFR and RBF appeared in all groups but significantly
in I and II. NaUE decrease and Na tubular reabsorption increase
were significant in all groups, more in the III and IV. These
results are compared with plasma renin activity and acute
therapeutic effect.
